ATI RN
Hematologic drugs Questions
Question 1 of 5
The vector of visceral leishmaniasis has geographical variations. In the Asian region the main vector is
Correct Answer: A
Rationale: The correct answer is A) Phlebotamus species. In the Asian region, Phlebotamus species serve as the main vector of visceral leishmaniasis. These sandfly species transmit the parasite responsible for causing the disease to humans when they bite. Understanding the specific vectors of diseases is crucial for effective prevention and control strategies. Option B) Lutzomyia species is more commonly associated with transmitting leishmaniasis in the Americas, not in the Asian region where the question is focused. Option C) Anopheles species are known for transmitting malaria, not leishmaniasis. Option D) Mansonia species are primarily associated with transmitting filarial worms, not leishmaniasis. Educationally, this question highlights the importance of understanding the geographical variations in disease vectors. It reinforces the need for healthcare professionals, especially those in regions where visceral leishmaniasis is endemic, to be knowledgeable about the specific vectors involved in disease transmission to implement appropriate control measures effectively.
Question 2 of 5
A pediatric nurse treating a 7-year-old female patient post status asthmaticus must understand that bronchodilators generally act by selectively
Correct Answer: A
Rationale: The correct answer is A) agonizing beta 2 adrenergic receptors in the bronchial smooth muscle. In the context of treating asthma, bronchodilators like albuterol work by stimulating these receptors, leading to smooth muscle relaxation and bronchodilation. This mechanism helps to relieve bronchoconstriction and improve airflow in conditions like status asthmaticus. Option B) antagonizing beta 2 adrenergic receptors in the bronchial smooth muscle is incorrect as it would have the opposite effect, causing bronchoconstriction instead of dilation, which is not desired in asthma management. Option C) agonizing alpha 1 adrenergic receptors in the myocardium is unrelated to bronchodilation and would not be the mechanism of action for bronchodilators used in treating asthma. Option D) antagonizing delta 2 adrenergic receptors in the bronchial smooth muscle is also incorrect as delta 2 adrenergic receptors are not typically targeted in bronchodilator therapy for asthma. Understanding the mechanism of action of bronchodilators is crucial for healthcare providers, especially pediatric nurses, as it guides their clinical decision-making when managing respiratory conditions in children. By grasping how these drugs work, nurses can better assess their effectiveness, anticipate potential side effects, and educate patients and families on the proper use of these medications.
Question 3 of 5
When treating a patient who's been taking tricyclic antidepressants for the past three months and has just been prescribed albuterol, a nurse should understand that
Correct Answer: C
Rationale: In this scenario, option C is the correct answer because tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs) can increase the risk of tachycardia and angina when taken with beta 2 adrenergic agonists like albuterol. This interaction can lead to cardiovascular complications due to the combined effects on heart rate and blood pressure. Option A is incorrect because TCAs are more likely to cause tachycardia rather than bradycardia when combined with beta 2 adrenergic agonists. Option B is incorrect as TCAs do not increase the risk of gastric ulcers, and they do not need to be taken with a fatty meal. Option D is incorrect as TCAs are not associated with pulmonary edema leading to peripheral edema and anasarca. Educationally, understanding drug interactions is crucial for healthcare professionals to ensure safe and effective patient care. This question highlights the importance of recognizing potential adverse effects when combining different classes of medications, emphasizing the need for thorough medication reconciliation and monitoring for drug interactions in clinical practice.
Question 4 of 5
A nurse treating a 57-year-old male in-patient who's been prescribed oral theophylline for long term control of COPD needs to monitor him for which of the following complications?
Correct Answer: A
Rationale: The correct answer is A) Dysrhythmias and seizures. Theophylline is a bronchodilator commonly used for long-term control of COPD. It works by relaxing the smooth muscles in the airways, making breathing easier. However, theophylline has a narrow therapeutic range, meaning that levels in the blood need to be carefully monitored to prevent toxicity. Dysrhythmias and seizures are potential complications of theophylline toxicity. The drug can cause cardiac dysrhythmias due to its stimulatory effects on the heart, which can lead to serious consequences like cardiac arrest. Seizures can also occur as theophylline affects the central nervous system. Option B) Thirst and polydipsia are not commonly associated with theophylline use. Option C) Hematuria and hypotension are also not typical side effects of theophylline. Option D) Anaphylactoid reactions are rare with theophylline and are not the primary concern when monitoring a patient on this medication. Educationally, understanding the potential complications of theophylline is crucial for nurses caring for patients with COPD. Monitoring for signs and symptoms of theophylline toxicity, such as dysrhythmias and seizures, is essential to ensure patient safety and optimize therapeutic outcomes. Regular monitoring of theophylline levels, as well as educating patients on the importance of compliance and recognizing signs of toxicity, are key aspects of managing patients on this medication.
Question 5 of 5
A nurse treating chronic asthmatic patients with methylxanthines must remember to increase the dosage when prescribing this medication simultaneously with
Correct Answer: B
Rationale: In the context of hematology and pharmacology, understanding drug interactions is crucial for safe and effective patient care. In this scenario, the correct answer is option B) Phenobarbital, phenytoin, and rifampin. Methylxanthines, like theophylline, are metabolized in the liver by the cytochrome P450 system. Phenobarbital, phenytoin, and rifampin are known to induce cytochrome P450 enzymes, leading to increased metabolism of methylxanthines. This accelerated metabolism can result in subtherapeutic levels of methylxanthines, reducing their effectiveness in treating chronic asthma. Option A) Cimetidine, ciprofloxacin, and other fluoroquinolone antibiotics are inhibitors of cytochrome P450 enzymes, which would lead to increased levels of methylxanthines, potentially causing toxicity rather than the desired therapeutic effect. Option C) Albuterol and TCAs do not significantly impact the metabolism of methylxanthines and do not require a dosage adjustment when used concurrently. Option D) None of the listed drugs pose a risk when taken with methylxanthines is incorrect because, as explained above, certain drugs can interact with methylxanthines, affecting their metabolism and efficacy. Educationally, this question highlights the importance of understanding drug interactions, especially in patients with chronic conditions like asthma who may be on multiple medications. Nurses need to be aware of potential interactions to ensure safe and effective pharmacological management for their patients.